Court Ruling Won't Stop PTAB's Review Of Vimovo Patent
The Patent Trial and Appeal Board decided Thursday to push ahead with its review of a patent covering Horizon Pharma's arthritis drug Vimovo, despite a district court ruling months ago the...To view the full article, register now.
Already a subscriber? Click here to view full article